共 107 条
[1]
Do K(2013)WEE1 kinase as a target for cancer therapy Cell Cycle 12 3159-3164
[2]
Doroshow JH(2014)The balance between cell cycle arrest and cell proliferation: control by the extracellular matrix and by contact inhibition Interface Focus 4 20130075-560
[3]
Kummar S(2015)Targeting the DNA damage response in cancer Mol Cell 60 547-4236
[4]
Gerard C(2012)Cyclin-dependent kinase suppression by WEE1 kinase protects the genome through control of replication initiation and nucleotide consumption Mol Cell Biol 32 4226-1677
[5]
Goldbeter A(1996)Cancer cell cycles Science 274 1672-8217
[6]
O’Connor MJ(2001)Radiosensitization of p53 mutant cells by PD0166285, a novel G(2) checkpoint abrogator Cancer Res 61 8211-3415
[7]
Beck H(2015)Phase I study of single-agent AZD1775 (MK-1775), a WEE1 kinase inhibitor, in patients with refractory solid tumors J Clin Oncol 33 3409-4380
[8]
Nahse-Kumpf V(2016)Phase I study evaluating WEE1 inhibitor AZD1775 as monotherapy and in combination with gemcitabine, cisplatin, or carboplatin in patients with advanced solid tumors J Clin Oncol 34 4371-84
[9]
Larsen MS(2020)Safety, pharmacokinetics, and clinical activity of adavosertib in combination with chemotherapy in asian patients with advanced solid tumors: Phase Ib study Target Oncol 15 75-4544
[10]
O’Hanlon KA(2017)Molecular pathways: targeting the protein kinase WEE1 in cancer Clin Cancer Res 23 4540-4361